HelixBind awarded grant from CARB-X to accelerate development of culture-free test for bloodstream infections

MARLBOROUGH, Mass., March 15, 2018 /PRNewswire/ -- HelixBind, Inc. announced a collaboration with CARB-X, (Combating Antibiotic Resistant Bacteria Accelerator), a global partnership funding the development of promising new antibacterial products and diagnostics. The company is eligible to...